Ochs H R
Klin Wochenschr. 1983 Mar 1;61(5):213-24. doi: 10.1007/BF01496127.
The onset and duration of action of benzodiazepines after single oral doses depend largely on absorption rate and the rate and extent of distribution. The rate and extent of accumulation during multiple dosage depend on elimination half-life and clearance. A framework is proposed for classification of benzodiazepines according to elimination half-life. Long acting benzodiazepines have half-life values usually exceeding 24 h. Drugs in this category have long-acting pharmacologically active metabolites, often desmethyldiazepam, accumulate extensively during multiple dosage, and may have impaired clearance in the elderly and those with liver disease. Intermediate and short-acting benzodiazepines have half-life values from 5-24 h and active metabolites are uncommon. Accumulation during multiple dosage is less extensive than with the long-acting group and diminishes as the half-life becomes shorter. Age and liver disease have a small influence on metabolic clearance. The half-life of ultrashort-acting benzodiazepines is less than 5 h. These drugs are essentially nonaccumulating. Pharmacokinetic classification may assist in understanding differences among benzodiazepines, but does not explain all of their clinical actions.
苯二氮䓬类药物单次口服后的起效时间和作用持续时间在很大程度上取决于吸收速率以及分布速率和程度。多次给药时的蓄积速率和程度则取决于消除半衰期和清除率。本文提出了一个根据消除半衰期对苯二氮䓬类药物进行分类的框架。长效苯二氮䓬类药物的半衰期通常超过24小时。该类药物具有长效的药理活性代谢产物,通常为去甲西泮,在多次给药期间会大量蓄积,在老年人和肝病患者中清除率可能受损。中效和短效苯二氮䓬类药物的半衰期为5至24小时,且活性代谢产物并不常见。多次给药时的蓄积程度不如长效组,且随着半衰期缩短而减轻。年龄和肝病对代谢清除率的影响较小。超短效苯二氮䓬类药物的半衰期小于5小时。这些药物基本不蓄积。药代动力学分类有助于理解苯二氮䓬类药物之间的差异,但并不能解释它们所有的临床作用。